Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021)
Introduction The COVID-19 outbreak poses a significant threat to the patients with tuberculosis (TB). TB and COVID-19 (TB–COVID) coinfection means the disease caused by both Mycobacterium tuberculosis and SARS-CoV-2 infection. Currently, the prevalence status, treatment and outcomes of the coinfecti...
Saved in:
Main Authors: | Qiang Sun, Hui Li, Jie Zhao, Xiaolin Wei, Quan Wang, Shasha Guo, Quanfang Dong, Ning Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e059396.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of Malaria and TB Coinfection at a National Tuberculosis Treatment Centre in Uganda
by: Joseph Baruch Baluku, et al.
Published: (2019-01-01) -
The November Exhibition
Published: (1905-01-01) -
Prevalence of dengue and leptospirosis coinfection and associated mortality rates: a systematic review and meta-analysis
by: Suraj Tiwari, et al.
Published: (2025-01-01) -
Mathematical Modelling of Tuberculosis and Hepatitis C Coinfection Dynamics with No Intervention
by: Mohammed Kizito, et al.
Published: (2024-01-01) -
Journal of a Frustrated Soul: John Henry Newman’s Dublin Diary (November 1853—March 1856) and the Perceived Failure of the Catholic University of Ireland
by: Pádraic Conway
Published: (2009-12-01)